CHA2DS2-VASc Stroke Risk Calculator
Estimate annual stroke risk in non-valvular atrial fibrillation by entering age, sex, and clinical risk factors.
Medical disclaimer: This tool is for educational use only and does not replace clinical judgment, diagnosis, or treatment decisions by a licensed clinician.
What is the CHA2DS2-VASc score?
The CHA2DS2-VASc score is a widely used clinical risk tool that helps estimate the chance of ischemic stroke in people with atrial fibrillation (AF), especially non-valvular AF. It expands the older CHADS2 model by adding more risk granularity, particularly for vascular disease, age 65–74, and sex category.
In everyday practice, clinicians use this score to decide whether anticoagulation should be discussed, considered, or strongly recommended. It is not the only factor in treatment planning, but it is an important starting point for shared decision-making.
How points are assigned
| Risk Factor | Points | Notes |
|---|---|---|
| Congestive heart failure / LV dysfunction | 1 | History of CHF or reduced left ventricular function. |
| Hypertension | 1 | Includes treated or untreated high blood pressure. |
| Age ≥ 75 years | 2 | Higher age contributes a larger stroke risk. |
| Diabetes mellitus | 1 | Type 1 or Type 2 diabetes. |
| Prior stroke/TIA/thromboembolism | 2 | Major historical risk marker. |
| Vascular disease | 1 | Examples: prior MI, peripheral arterial disease, aortic plaque. |
| Age 65–74 years | 1 | Used only if age is under 75. |
| Sex category (female) | 1 | Applied as a risk modifier in many guidelines. |
How to interpret your result
The higher the total score, the higher the expected annual stroke risk in historical AF cohorts. Many clinicians interpret score thresholds by sex:
- Men: 0 = low risk, 1 = consider anticoagulation, 2+ = anticoagulation generally recommended.
- Women: 1 (sex alone) = low risk, 2 = consider anticoagulation, 3+ = anticoagulation generally recommended.
Keep in mind that treatment decisions also consider bleeding risk, patient preference, kidney function, fall risk, drug interactions, and adherence.
CHADS2 vs CHA2DS2-VASc: what changed?
The original CHADS2 score was simple and useful, but it left many people grouped into a broad intermediate-risk category. CHA2DS2-VASc provides more precision by:
- Separating age into two tiers (65–74 and 75+),
- Adding vascular disease,
- Including sex category as a modifier.
This improved stratification helps identify truly low-risk patients and better supports individualized prevention plans.
Practical tips when using a calculator
1) Verify each diagnosis
Before assigning points, confirm whether a condition is truly present in the medical record. For example, controlled hypertension still counts in most frameworks.
2) Use age only once
Age contributes either 1 point (65–74) or 2 points (75+), not both. This calculator handles that automatically.
3) Don’t forget clinical context
Stroke prevention in AF is never just a number. Use this output to support a conversation, not replace it. If you are a patient, bring your score to your clinician and discuss benefits and risks of therapy.
Frequently asked questions
Is this a diagnosis tool?
No. It estimates stroke risk once AF has already been diagnosed by a clinician.
Does this include bleeding risk?
No. Bleeding risk tools (such as HAS-BLED) are separate and should be reviewed in parallel.
Can I use this if I don’t have AF?
Not as intended. The score is specifically validated for atrial fibrillation stroke-risk stratification.
Bottom line
A good CHA2DS2-VASc calculator helps translate clinical history into a consistent score, making stroke prevention decisions clearer. Use the calculator above as a fast reference, then confirm next steps with your healthcare team.